2m 2m 2m 2m 2m 2m 2m
PRIME MEDICINE (PRME)
NASDAQ
$3.00+$0.010 (+0.33%)
Price as of Oct 02, 2026 5:16 PM EDT- $542.3MMarket Cap
- -55.17%1-Year Change
- BiotechnologyIndustry
PRIME MEDICINE (PRME)
$3.00+$0.010 (+0.33%)
PRME | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.99 | ||
Change | -$0.06 (-2.13%) | ||
Open | $3.05 | ||
High | $3.10 | ||
Low | $2.98 | ||
Previous Close | $3.06 | ||
Volume | 2,829,698 | ||
30-Day Average Volume | 3,245,008 | ||
1-Week Change | -2.61% | ||
1-Month Change | -16.25% | ||
1-Year Change | -55.17% | ||
3-Year Change | -68.66% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 181.4M | ||
Total Assets | $249.0M | ||
Market Cap | $542.3M | ||
Enterprise Value | $494.9M | ||
Period: QTR TTM FY | |||
Revenue | $1.2M | ||
Net Income | -$42.1M | ||
Free Cash Flow | -$41.1M | ||
EBIT | -$42.1M | ||
EBITDA | -$40.3M | ||
Net Working Capital | $65.1M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 429 | ||
P/B | 14 | ||
P/E | -12 | ||
PEG | -1 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/10/2019 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue